School of Medicine
Showing 1-10 of 22 Results
-
Caleb Lareau
Postdoctoral Research Fellow, Pathology
Bio Postdoctoral research fellow interested in computational biology, single-cell genomics, immunology, and machine learning.
-
Sumin Lee
Postdoctoral Research Fellow, Pathology
Current Research and Scholarly Interests Staphylococcus aureus is a commensal human pathogen that is a major cause of infections worldwide. The new methods for visualizing the site of infection and subsequent response to treatment would greatly improve current clinical management of S. aureus infection.I aim to develop imaging tool to monitor infection in vivo that make use of small molecule activity-based probes (ABPs) that specifically target a family of serine hydrolases enzymes in S. aureus.
-
Tristan Lerbs
Postdoctoral Research Fellow, Pathology
Bio 1997 - 2006: High school, Bonn, Germany
2007 - 2008: Police officer training, Hahn, Germany
2008 - 2015: Medical training, Heidelberg, Germany
2015 - 2016: Resident in General Surgery, Eschweiler, Germany
2016: Resident in Internal Medicine, Aachen, Germany -
Robert Kazimierz Lesniak
Instructor, Pathology
Bio Robert K. Le?niak joined the Medicinal Chemistry Knowledge Center at Stanford ChEM-H in 2018 as a postdoctoral fellow. Prior to coming to Stanford, he worked with Professor Chris Schofield at the University of Oxford, as a postdoctoral research associate, designing novel antibiotics for the European gram-negative antibacterial engine (ENABLE) and UK Medical Research Council (MRC). Dr Le?niak also completed his DPhil under the guidance of Professor Schofield as a BHF-CRE studentship recipient, which involved the design and implementation of small molecules targeting Fe(II), 2-oxoglutarate dependent oxygenase enzymes involved in carnitine biosynthesis and hypoxic response as a means to treat cardiovascular disease. In addition, work on small-molecule modulation of bacterial metallo-beta-lactamases to combat antibiotic resistance was also carried out. Dr Le?niak completed his undergraduate at the University of Bristol, and worked at GlaxoSmithKline, North Carolina, developing inhibitors of bromodomains and histone acetyl-transferases. He is currently working with Professor Thomas Montine at the Stanford School of Medicine on the design of neurotransmitter prodrugs.
